EuroPharm Forum Observatory
The purpose of the EuroPharm Forum Observatory is to collect and display information in order to develop pharmacy practice. Hopefully knowlegde on the EuroPharm Forum Obsevatory is spred worldwide and people with interest in pharmacy practice will use and contribute to the Observatory.
The EuroPharm Forum Observatory is a wiki, which is owned and maintained by EuroPharm Forum in collaboration with WHO Collaboration Centre, Pharmakon. However everyone with an interest in development of pharmacy practice may use and contribute to the site.
The EuroPharm Forum Observatory is divided into five elements. Each element has it's own purpose and structure.
|
Evidence-based Pharmacy Practice
WHO CC, Pharmakon has for several different areas made an evidence based report on the area with conclusions. Thise reports are frequently updated with new reference and the conclusions reviewed.
|
Public Health and Pharmacy Practice Policy Documents
Links to importants documents grouped by owner and with extensive keywords in order to easily find the document and relevant documents via the search facility.
|
|
EuroPharm Forum Working Groups
The Professional Programme of the EuroPharm Forum reflects a WHO priority and seeks to involve pharmacists in the WHO efforts to improve patient care and chronic disease management and support health promotion and well-being through lifestyle counselling services. Each professional programme area comprises one or more Working Groups.
|
Discussion on Special Pharmacy-related Topics
If you don't find information on the topic you are searching for, you may create your own discussion and invite other users to contribute.
|
|
Pharmacy Practice events
Conferences, seminars, meetings etc are listed here. If you are planning an event, you can check that your participants are not available due to other events and you may also contribute and get your own events listed.
|
|
The access to the EuroPharm Forum Observatory is protected by password. This in order to be able to create statistics. However as everybody is welcome to contribute.
Comments (0)
You don't have permission to comment on this page.